Skip to content

EsoBiotec: what changed

BE 0756.885.159NACE 72.109, Other research and development on natural sciencesOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€7.7m
2024 · -€6.9m+€14.6m
Equity
€12.4m
2024 · €1.5m+€10.9m
Cash
€113,183
2024 · €1.3m-€1.2m
Balance sheet total
€16.5m
2024 · €4.3m+€12.2m

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€15.8m

    up €15.8m (+2,888%), from €547,837 to €16.4m

    of which Other amounts receivable: +€15.9m

  • Current investments -€1.4m

    no longer reported in 2025; in 2024 it stood at €1.4m

  • Cash -€1.2m

    down €1.2m (-91.3%), from €1.3m to €113,183

    mainly Receivables within one year (-€15.8m) and Investment in fixed assets (net) (-€6.0m)

  • Tangible fixed assets -€979,735

    no longer reported in 2025; in 2024 it stood at €979,735

Equity and liabilities
  • Profit (loss) carried forward +€7.7m

    up €7.7m (+71.9%), from -€10.7m to -€3.0m

  • Tax, wage and social debts +€3.5m

    up €3.5m (+1,797%), from €192,392 to €3.7m

    of which Taxes: +€3.6m

  • Contributions +€3.2m

    up €3.2m (+25.9%), from €12.3m to €15.4m

  • Debts after one year -€905,201

    no longer reported in 2025; in 2024 it stood at €905,201

  • Trade debts -€688,966

    down €688,966 (-63.4%), from €1.1m to €398,138

Income statement
  • Gross operating margin +€27.5m

    up €27.5m, from -€761,751 to €26.8m

  • Taxes +€4.3m

    up €4.3m, from -€268,289 to €4.1m

  • Staff costs +€1.6m

    up €1.6m (+157%), from €1.0m to €2.6m

  • Depreciation +€1.5m

    up €1.5m (+28.7%), from €5.4m to €6.9m

  • Financial income +€1.0m

    up €1.0m (+1,894%), from €54,116 to €1.1m

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€6.9m
Gross operating margin +€27.5m
Staff costs -€1.6m
Depreciation -€1.5m
Other operating charges -€104,100
Other operating items -€6.0m
Financial income +€1.0m
Financial charges -€327,051
Taxes -€4.3m
Result 2025 €7.7m
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€1.3m
Investment -€4.5m
Financing +€2.0m
Cash 2024 €1.3m
Net result for the year +€7.7m
Depreciation +€6.9m
Receivables within one year -€15.8m
Deferred charges and accrued income +€51,383
Trade debts -€688,966
Tax, wage and social debts +€3.5m
Other debts -€377,911
Accrued charges and deferred income +€18,220
Investment in fixed assets (net) -€6.0m
Current investments +€1.4m
Debts after one year -€905,201
Current portion of long-term debt -€231,943
Contributions, distributions and other +€3.2m
Cash 2025 €113,183
brings cash intakes cash out
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €4,297,659 €16,481,399 +€12.2m +283%
Fixed assets 21/28 €980,799 €501 -€980,298 -99.9%
Tangible fixed assets 22/27 €979,735 - -€979,735
Plant, machinery and equipment 23 €209,454 - -€209,454
Furniture and vehicles 24 €319,205 - -€319,205
Leasing and similar rights 25 €451,076 - -€451,076
Financial fixed assets 28 €1,064 €501 -€563 -52.9%
Current assets 29/58 €3,316,860 €16,480,898 +€13.2m +397%
Amounts receivable within one year 40/41 €547,837 €16,367,715 +€15.8m +2,888%
Trade receivables 40 €32,010 - -€32,010
Other amounts receivable 41 €515,827 €16,367,715 +€15.9m +3,073%
Current investments 50/53 €1,411,913 - -€1.4m
Cash at bank and in hand 54/58 €1,305,728 €113,183 -€1.2m -91.3%
Deferred charges and accrued income 490/1 €51,383 - -€51,383
Total equity and liabilities 10/49 €4,297,659 €16,481,399 +€12.2m +283%
Equity 10/15 €1,503,109 €12,414,984 +€10.9m +726%
Contributions 10/11 €12,253,000 €15,432,208 +€3.2m +25.9%
Capital 10 €12,253,000 €15,432,208 +€3.2m +25.9%
Issued capital 100 €12,253,000 €15,432,208 +€3.2m +25.9%
Profit (loss) carried forward 14 -€10,749,891 -€3,017,225 +€7.7m +71.9%
Amounts payable 17/49 €2,794,550 €4,066,415 +€1.3m +45.5%
Amounts payable after more than one year 17 €905,201 - -€905,201
Financial debts 170/4 €905,201 - -€905,201
Amounts payable within one year 42/48 €1,889,349 €4,048,195 +€2.2m +114%
Current portion of amounts payable after more than one year 42 €231,943 - -€231,943
Trade debts 44 €1,087,104 €398,138 -€688,966 -63.4%
Suppliers 440/4 €1,087,104 €398,138 -€688,966 -63.4%
Taxes, remuneration and social security 45 €192,392 €3,650,057 +€3.5m +1,797%
Taxes 450/3 €42,532 €3,648,868 +€3.6m +8,479%
Remuneration and social security 454/9 €149,860 €1,189 -€148,671 -99.2%
Other amounts payable 47/48 €377,911 - -€377,911
Accrued charges and deferred income 492/3 - €18,220 +€18,220
Non-recurring operating income 76A - €42,611,215 +€42.6m
Remuneration, social security and pensions 62 €1,018,115 €2,619,703 +€1.6m +157%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €5,386,699 €6,933,238 +€1.5m +28.7%
Other operating charges 640/8 - €104,100 +€104,100
Non-recurring operating charges 66A - €6,032,728 +€6.0m
Gross operating margin 9900 -€761,751 €26,772,082 +€27.5m
Operating profit (loss) 9901 -€7,166,565 €11,082,313 +€18.2m
Financial income 75/76B €54,116 €1,079,052 +€1.0m +1,894%
Recurring financial income 75 €54,116 €1,079,052 +€1.0m +1,894%
Financial charges 65/66B €31,202 €358,254 +€327,051 +1,048%
Recurring financial charges 65 €31,202 €358,254 +€327,051 +1,048%
Profit (loss) for the period before taxes 9903 -€7,143,651 €11,803,112 +€18.9m
Income taxes 67/77 -€268,289 €4,070,445 +€4.3m
Profit (loss) for the period 9904 -€6,875,362 €7,732,667 +€14.6m
Profit (loss) for the period to be appropriated 9905 -€6,875,362 €7,732,667 +€14.6m

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€12.4m to €12.4m

Midpoint €12.4m · adjusted equity only

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €12.4m
Indication €12.4m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€12,414,984
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€12.4m

Capitalised earnings

net result for the year (9904)
2025
€7,732,667
excluding non-recurring income and charges
-€28,845,820
2024
-€6,875,362
2023
-€2,673,233
excluding non-recurring income and charges
-€2,106,206
2022
-€1,002,978
2021
-€198,317
Average result, excluding non-recurring income and charges
-€12,609,130
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 20 November 2026 via checked.be.